InFocus: Life Sciences & Healthcare e-newsletter - July 2006

In this issue we discuss:

• The pitfalls of co-ownership of IPRs in the UK
• Damages in UK patent actions post implementation of the Enforcement Directive
• UKPO limits monopoly claims to DNA sequences used as research tools
• Biosimilars - the road to regulatory approval
• WTO set to endorse finding that de fact ban on GM crops unfair barrier to trade

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing’s top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.